TIFFANY LERAY: Open Payments
NPI 1730588633 · BOWIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$346 in 14 payments from 10 companies in 2025. Trend: 2023 $155 · 2024 $313 · 2025 $346
Food & beverage: $346
| Company | Payments | Amount |
|---|---|---|
| Sage Therapeutics, LLC | 2 | $67 |
| MILLICENT US INC | 3 | $58 |
| Astellas Pharma US Inc | 2 | $49 |
| Organon LLC | 1 | $33 |
| SHIELD THERAPEUTICS INC | 1 | $33 |
| SANOFI PASTEUR INC. | 1 | $29 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $24 |
| OptumHealth Care Solutions, LLC | 1 | $21 |
| Exeltis, USA Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
Products named: ZURZUVAE, Veozah, FEMLYV, NEXPLANON, ACCRUFER, BEYFORTUS, FEMRING, VIVIFY HEALTH CARE TEAM PORTAL 001.
Industry payments across MD — which companies pay providers there.
